Steven R. Mitchell - 30 Apr 2025 Form 4 Insider Report for ASPEN AEROGELS INC (ASPN)

Role
Director
Signature
/s/ Virginia H. Johnson, Attorney-in-Fact
Issuer symbol
ASPN
Transactions as of
30 Apr 2025
Net transactions value
$0
Form type
4
Filing time
01 May 2025, 20:52:09 UTC
Previous filing
07 Apr 2025
Next filing
16 May 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ASPN Common Stock Award $0 +10,370 +7.6% $0.000000 146,528 30 Apr 2025 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ASPN Stock Options (Right to Buy) Award $0 +9,105 $0.000000 9,105 30 Apr 2025 Common Stock 9,105 $5.40 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person was granted Restricted Stock Units ("RSUs") representing a portion of the annual grant of equity for service as a non-employee director pursuant to the Issuer's Non-Employee Director Compensation Policy. Each RSU represents the right to receive one share of Common Stock upon vesting. These RSUs will vest on the earlier of (a) April 30, 2026, or (b) the day prior to the Issuer's annual meeting of stockholders to be held in 2026.
F2 Represents 136,158 shares of Common Stock and 10,370 RSUs
F3 The reporting person was granted options representing the remaining portion of the annual grant of equity for service as a non-employee director pursuant to the Issuer's Non-Employee Director Compensation Policy. The options will vest on the earlier of (a) April 30, 2026, or (b) the day prior to the Issuer's annual meeting of stockholders to be held in 2026.